NEW YORK, Jan. 9, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd." or the "Company") (NASDAQ: TLX) of a class action securities ...
RADNOR, Pa., Feb. 18, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities fraud class action lawsuit has been filed against Ultragenyx ...
-- Who: Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) -- What: Securities fraud class action lawsuit filed -- Class Period: August 3, 2023, through December 26, 2025 -- Deadline to seek lead plaintiff ...
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or ...
A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between February 21, 2025 and August 28, 2025. If you have any questions about this class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results